Menu
GeneBe

20-44355807-G-A

Variant summary

Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong

The NM_175914.5(HNF4A):c.3G>A(p.Met1?) variant causes a start lost change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★★).

Frequency

Genomes: not found (cov: 32)

Consequence

HNF4A
NM_175914.5 start_lost

Scores

6
6
3

Clinical Significance

Likely pathogenic reviewed by expert panel P:2

Conservation

PhyloP100: 5.87
Variant links:
Genes affected
HNF4A (HGNC:5024): (hepatocyte nuclear factor 4 alpha) The protein encoded by this gene is a nuclear transcription factor which binds DNA as a homodimer. The encoded protein controls the expression of several genes, including hepatocyte nuclear factor 1 alpha, a transcription factor which regulates the expression of several hepatic genes. This gene may play a role in development of the liver, kidney, and intestines. Mutations in this gene have been associated with monogenic autosomal dominant non-insulin-dependent diabetes mellitus type I. Alternative splicing of this gene results in multiple transcript variants encoding several different isoforms. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 20 ACMG points.

PVS1
Start lost variant, no new inframe start found.
PS1
Another start lost variant in NM_175914.5 (HNF4A) was described as [Likely_pathogenic] in ClinVar as 689636
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 20-44355807-G-A is Pathogenic according to our data. Variant chr20-44355807-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1299751.Status of the report is reviewed_by_expert_panel, 3 stars. Variant chr20-44355807-G-A is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HNF4ANM_175914.5 linkuse as main transcriptc.3G>A p.Met1? start_lost 1/10 ENST00000316673.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HNF4AENST00000316673.9 linkuse as main transcriptc.3G>A p.Met1? start_lost 1/101 NM_175914.5 P41235-5
HNF4AENST00000457232.5 linkuse as main transcriptc.3G>A p.Met1? start_lost 1/101 P41235-6
HNF4AENST00000609795.5 linkuse as main transcriptc.3G>A p.Met1? start_lost 1/81 P41235-7
HNF4AENST00000609262.5 linkuse as main transcriptc.-229G>A 5_prime_UTR_variant 1/41

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Monogenic diabetes Pathogenic:1
Likely pathogenic, reviewed by expert panelcurationClinGen Monogenic Diabetes Variant Curation Expert PanelApr 06, 2024The c.3G>A variant in the hepatocyte nuclear factor -4 alpha gene, HNF4A, results in a start loss at the initiation codon in NM_175914.4. By altering the start codon of the coding sequence, this variant may cause a truncated or absent protein in a gene in which loss-of-function is an established disease mechanism (PVS1_Strong; PMID: 23348805). In addition, this variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant was identified in an individual with a clinical history highly specific for HNF4A-MODY (MODY probability calculator result >50%, negative genetic testing for HNF1A, and negative diabetes autoantibodies (PP4_Moderate; PMID: 30977832, internal lab contributors). In summary, c.3G>A meets the criteria to be classified as Likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 2.0.0, approved 10/11/2023: PVS1_Strong, PM2_Supporting, PP4_Moderate. -
Maturity-onset diabetes of the young type 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingExeter Molecular Genetics LaboratoryOct 05, 2021The c.3G>A variant in the HNF4 homeobox A gene, HNF4A, results in the loss of the initiation codon (p.Met1?) in exon 1 of the pancreatic specific HNF4A isoform NM_175914.5. By altering the start codon of the coding sequence, this variant may cause a truncated or absent protein in a gene in which loss-of-function is an established disease mechanism (PVS1_Moderate; PMID: 23348805). This variant is absent in gnomAD v2.1.1 (PM2_Supporting), and was identified in two unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes (PMID:21683639, PMID:30977832). However, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold. One of these individuals had a clinical history highly specific for HNF4A-MODY (MODY probability calculator result >50%, negative genetic testing for HNF1A, and antibody negative) (PP4_Moderate; PMID:30977832). This variant also segregated with diabetes, with two informative meioses in the published family (PMID:21683639) but this is an insufficient number of meiosis to meet PP1 criteria. A different variant at that also results in the loss of the initiation codon has been identified by our laboratory and classified as likely pathogenic (PS1_Supporting). In summary, c.3G>A meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied: PVS1_Moderate, PS1_Supporting, PP4_Moderate, PM2_Supporting. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.38
D
BayesDel_noAF
Pathogenic
0.31
Cadd
Uncertain
23
Dann
Uncertain
1.0
Eigen
Uncertain
0.38
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.90
D;D;D
M_CAP
Pathogenic
0.94
D
MetaRNN
Pathogenic
0.99
D;D;D
MetaSVM
Uncertain
0.68
D
MutationTaster
Benign
1.0
D;D
PROVEAN
Benign
-0.34
N;.;N
REVEL
Pathogenic
0.66
Sift
Pathogenic
0.0
D;.;D
Sift4G
Benign
0.29
T;T;T
Polyphen
0.66, 0.39
.;P;B
Vest4
0.94
MutPred
0.99
Gain of catalytic residue at S3 (P = 0.0992);Gain of catalytic residue at S3 (P = 0.0992);Gain of catalytic residue at S3 (P = 0.0992);
MVP
0.97
ClinPred
0.93
D
GERP RS
5.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr20-42984447; API